NCT03263611View on ClinicalTrials.gov

AMG0103 in Subjects With Chronic Discogenic Lumbar Back Pain

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

February 26, 2018

Primary Completion Date

February 15, 2021

Study Completion Date

February 15, 2021

Conditions
Degenerative Disc Disease
Interventions
DRUG

Placebo

single intradiscal injection

DRUG

AMG0103

single intradiscal injection

Trial Locations (6)

33614

Florida Medical Relief, Tampa

33709

Florida Medical Pain Management, St. Petersburg

60612

Rush University Medical Center, Chicago

90033

Keck Medicine of USC, Los Angeles

92037

University of California San Diego, San Diego

92120

Spine Institute of San Diego, San Diego

All Listed Sponsors
lead

AnGes, Inc.

INDUSTRY

NCT03263611 - AMG0103 in Subjects With Chronic Discogenic Lumbar Back Pain | Biotech Hunter | Biotech Hunter